Exogenous supplementation of antithrombin III in adult and pediatric patients receiving extracorporeal membrane oxygenation

Abstract

Administration of antithrombin III improved anti-Xa levels in both populations, however, did not significantly reduce heparin rates. Our findings suggest that the use of antithrombin III restores heparin responsiveness in patients with low antithrombin III activity and low anti-Xa activity.